Found: 79
Select item for more details and to access through your institution.
Automated production of <sup>11</sup>C‐labeled carboxylic acids and esters via "in‐loop" <sup>11</sup>C‐carbonylation using GE FX synthesis modules.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 6, p. 217, doi. 10.1002/jlcr.4058
- By:
- Publication type:
- Article
Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging.
- Published in:
- Molecular Imaging, 2024, p. 1, doi. 10.1177/15353508241245265
- By:
- Publication type:
- Article
Zinc‐Mediated Radiosynthesis of Unprotected Fluorine‐18 Labelled α‐Tertiary Amides.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 2, p. 1, doi. 10.1002/ange.202316365
- By:
- Publication type:
- Article
Zinc‐Mediated Radiosynthesis of Unprotected Fluorine‐18 Labelled α‐Tertiary Amides.
- Published in:
- Angewandte Chemie International Edition, 2024, v. 63, n. 2, p. 1, doi. 10.1002/anie.202316365
- By:
- Publication type:
- Article
GABA A Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson's Disease.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 12, p. 1711, doi. 10.3390/brainsci13121711
- By:
- Publication type:
- Article
Ethical Considerations for Artificial Intelligence in Medical Imaging: Data Collection, Development, and Evaluation.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1848, doi. 10.2967/jnumed.123.266080
- By:
- Publication type:
- Article
Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023).
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00224-0
- By:
- Publication type:
- Article
Cholinergic system correlates of postural control changes in Parkinson's disease freezers.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 8, p. 3243, doi. 10.1093/brain/awad134
- By:
- Publication type:
- Article
Applications of radiolabeled antibodies in neuroscience and neuro‐oncology.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2023, v. 66, n. 9, p. 269, doi. 10.1002/jlcr.4049
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00192-5
- By:
- Publication type:
- Article
SNMMI Clinical Trial Network Research Series for Technologists: Application of Good Clinical Practice to Clinical Research in Medical Imaging.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Preparation and Evaluation of 64 Cu-Radiolabled Dual-Ligand Multifunctional Gold Nanoparticles for Tumor Theragnosis.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 1, p. 71, doi. 10.3390/ph16010071
- By:
- Publication type:
- Article
Progression of regional cortical cholinergic denervation in Parkinson's disease.
- Published in:
- Brain Communications, 2022, v. 4, n. 6, p. 1, doi. 10.1093/braincomms/fcac320
- By:
- Publication type:
- Article
Differential cholinergic systems' changes in progressive supranuclear palsy versus Parkinson's disease: an exploratory analysis.
- Published in:
- Journal of Neural Transmission, 2022, v. 129, n. 12, p. 1469, doi. 10.1007/s00702-022-02547-9
- By:
- Publication type:
- Article
Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1949, doi. 10.2967/jnumed.122.263864
- By:
- Publication type:
- Article
Development of Fluorinated NP-59: A Revival of Cholesterol Utilization Imaging with PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263864
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
Unnatural amino acids offer new hope for accurate bacterial infection PET imaging in prosthetic joint infection.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Development of Fluorinated NP-59: A Revival of Cholesterol Utilization Imaging with PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263864
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer--Use of Imaging Agents in Therapeutic Drug Development and Approval.
- Published in:
- Journal of Nuclear Medicine Technology, 2022, v. 50, n. 3, p. 1, doi. 10.2967/jnmt.122.264372
- By:
- Publication type:
- Article
Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson's disease: correlation with postural and gait deficits.
- Published in:
- Journal of Neural Transmission, 2022, v. 129, n. 8, p. 1001, doi. 10.1007/s00702-022-02523-3
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
Development of Fluorinated NP-59: A Revival of Cholesterol Utilization Imaging with PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263864
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer- Use of Imaging Agents in Therapeutic Drug Development and Approval.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Editorial: Positron Emission Tomography (PET) Imaging of Brain Biochemistry: Beyond High-Affinity Radioligands.
- Published in:
- Frontiers in Neuroscience, 2022, p. 1, doi. 10.3389/fnins.2022.907460
- By:
- Publication type:
- Article
Development of Fluorinated NP-59: A Revival of Cholesterol Utilization Imaging with PET.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.122.263864
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
Synthesis of <sup>68</sup>Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced <sup>68</sup>Ga as exemplified by [<sup>68</sup>Ga]Ga-PSMA-11 for prostate cancer PET imaging.
- Published in:
- Nature Protocols, 2022, v. 17, n. 4, p. 980, doi. 10.1038/s41596-021-00662-7
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
Proceedings: PET Drugs: A Workshop on Inspections Management and Regulatory Considerations.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263443
- By:
- Publication type:
- Article
Preclinical evaluation of (S)-[<sup>18</sup>F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 49, n. 1, p. 125, doi. 10.1007/s00259-021-05495-w
- By:
- Publication type:
- Article
Synthesis and Evaluation of a Fluorine-18 Radioligand for Imaging Huntingtin Aggregates by Positron Emission Tomographic Imaging.
- Published in:
- Frontiers in Neuroscience, 2021, v. 15, p. 1, doi. 10.3389/fnins.2021.766176
- By:
- Publication type:
- Article
A comprehensive assessment of <sup>68</sup>Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262412
- By:
- Publication type:
- Article
Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262567
- By:
- Publication type:
- Article
PSMA PET validates higher rates of metastatic disease for European Association of Urology Biochemical Recurrence Risk Groups: an international multicentre study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262821
- By:
- Publication type:
- Article
A comprehensive assessment of 68Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262412
- By:
- Publication type:
- Article
A comprehensive assessment of <sup>68</sup>Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262412
- By:
- Publication type:
- Article
Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262567
- By:
- Publication type:
- Article
A comprehensive assessment of <sup>68</sup>Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262412
- By:
- Publication type:
- Article
PSMA PET validates higher rates of metastatic disease for European Association of Urology Biochemical Recurrence Risk Groups: an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262821
- By:
- Publication type:
- Article
Preliminary Evaluations of [<sup>11</sup>C]Verubulin: Implications for Microtubule Imaging With PET.
- Published in:
- Frontiers in Neuroscience, 2021, v. 15, p. 1, doi. 10.3389/fnins.2021.725873
- By:
- Publication type:
- Article
A comprehensive assessment of <sup>68</sup>Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262412
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-021-00128-x
- By:
- Publication type:
- Article
Iridium‐katalysierte C‐H‐Borylierung von Heteroarenen: Eine Balance zwischen sterischer and elektronischer Regiokontrolle.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 6, p. 2830, doi. 10.1002/ange.202001520
- By:
- Publication type:
- Article
Iridium‐Catalysed C−H Borylation of Heteroarenes: Balancing Steric and Electronic Regiocontrol.
- Published in:
- Angewandte Chemie International Edition, 2021, v. 60, n. 6, p. 2796, doi. 10.1002/anie.202001520
- By:
- Publication type:
- Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020).
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2021, v. 6, n. 1, p. 1, doi. 10.1186/s41181-020-00118-5
- By:
- Publication type:
- Article
Cyclotron-based production of <sup>68</sup>Ga, [<sup>68</sup>Ga]GaCl<sub>3</sub>, and [<sup>68</sup>Ga]Ga-PSMA-11 from a liquid target.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1186/s41181-020-00106-9
- By:
- Publication type:
- Article
Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC).
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1186/s41181-020-00110-z
- By:
- Publication type:
- Article